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In our previous studies we established that in normal conditions rat thrombo-
cytopoiesis and plasma thrombocytopoietin act ivi ty depended directly on the 
functional state of beta-adrenergic receptors (7, 8) . The aim of the present work 
is to determine the extent to which non-selective beta-adrenergic actions influence 
thrombocyte and megakaryocyte number in thromboplastin induced acute 
thrombocytopenia. I t w i l l permit us to establish the role of beta-adrenergic re-
ceptors in thrombocytopoiesis regulation in extreme conditions. 
Material and methods 
The study covered 53 white male rats of Wistar breed with 180—200 g body 
weight divided into three groups. I s t — injected with Isoprenaline ( I P ) hydro-
chloride (a non-selective beta-adrenostimulator) at dosis 2 x 3 mg/kg b. \ v . ; 
I I n d — wi th Propranolol ( P R ) hydrochloride (a non-selective beta-adreno-
blocker) at dosis 2 x 5 mg/kg b. w. , and I I I r d — with saline (PS) in 
the same amount (controls). The experiment duration was 24 h and the 
injections wi th adrenergic agents and P S twice every 12 h intraperitoneally. 
3 h after first injection thromboplastin ( T P ) was injected after the scheme 
of Kelemen et a l . (1963) in our modification. T P produced by the R e -
search Institute of Hematology and Transfusion — Sofia was used in our stu-
dy. The first injection was done i . v . in the ta i l ve in in vo l . 0,5.10—6 m 3 but the 
second one after 40 min intraperitoneally in v o l . 1.10—6 m 3 .Thrombocyte count 
was determined after the method of Feiss ly-Li id in (cited after 9) at the beginning 
and the end of the assay as well as megakaryocyte line cells of 33 animals only 
by using bone-marrow smears prepared after the routine method (9). Megakaryo-
cyte classification was done after Levine et a l . (1982). The data were processed 
by the methods of variat ion statistics. 
Results and discussion 
The comparison of the changes of thrombocyte count shows that it increases 
insignificantly (0,75 per cent) in I P + T R treated animals, it decreases with 51,97 per 
cent (p <0,001) in P R + T R treated ones but wi th 30,96 per cent (p <0,002) in P S + T R 
treated ones (see fig. 1). The changes of bone-marrow megakaryocytes (see table 1). 
show that I P - f T R treatment causes a total megakaryocyte increase with 50 per 
cent (p<0,001). I s t and I I n d stage megakaryocytes decreased with 49 per cent 
(p<0,001) and 3,20 per cent, respectively, but I I I r d and I V t h stage ones increased 
with 161 per cent (p<0,001) and 263 per cent (p<0,001), respectively. In P R - f 
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5"R treated animals megakaryocytes increased totally with 44 per cent (p<0,001) 
{ I s t stage with 52 per cent (p<0,001); I I n d one with 71 per cent (p<0,001) , and 
H [ d one with 39 per cent) while I V t h stage megakaryocytes decreased wi th 54 per 
Icent. 
I I t is evident that I P + T R injection induces an insignificant thrombocyte and 
a strongly expressed megakaryocyte increase (totally on the account of more ma­
tured forms — I I I r d and fourth stages) while t 
P ' stage megakaryocytes are significantly * х ю ' / t 
Teduced. I t is known that T R injection in­
duces thrombocyte diminution and a paral­
le l plasma thrombocytopoietin act ivi ty in-
lse up to 24 t h hour (14) which is one of 
е reasons for megakaryocyte increase and 
Reduced thrombocyte count restoration. The 
comparison of I P - f - T R treated thrombo­
cytes with the other two groups shows that 
©nly they have reached their in i t ia l levels 
B t the end of the experiment. We suppose 
[that I P and non-selective beta-adrenosti-
Bnulation respectively, is an important fac-
or for thrombocyte number restitution in 
fextreme conditions. Probably, I P is rela­
ted with the strongly expressed increase 
Ш I I I r d and I V t h stage megakaryocytes, 
loo , and sets the pattern for the signi­
ficant I s t stage megakaryocytes reduction. 
W e established analogous changes in these 
cells under I P influence also in normal conditions of the animals (7). We 
ccept that most probably I P exerts a direct stimulating effect upon beta-adre­
nergic receptors of stem cells and the cells of megakaryocyte line as far as such 
an effect was demonstrated in other blood cell systems ( 1 , 2, 11). I t is known that 
I P stimulates directly beta-adrenergic receptors of early precursors and unipotent 
stem cells as well as of more matured erythroid elements (2, 11) and causes an in ­
creased DNA synthesis, incorporation of cells into cell cycle and shortening of 
the latter. I n our opinion, I P induces similar changes also in megakaryocyte line 
which is expressed in a strong megakaryocyte number increase accompanied by 
mature forms prevalence and in thrombocyte count augmentation. I t is l ikely 
that I P acting on different processes (carbohydrate and fat metabolism, Ley dig 
cell steroidogenesis, 7 6Se-methionine incorporation, etc. — 7, 13, 16, 18) s t imula­
tes additionally the processes of proliferation and differentiation resulting in ma­
ture cellular forms increase. I P total effect can be also related with the possible 
suppression of thrombosthenin production which reduces thrombocyte count (4, 
5) . Thrombocyte reduction with 51,97 per cent and significant total increase of 
megakaryocytes under P R + T R treatment allows us to accept that there is mega-
karyocytopoiesis stimulation with suppression of thrombocyte formation. It is 
evident that megakaryocyte increase is mainly on the account of these of the 
first two stages and, part ial ly, of the third one, while mature megakaryocytes 
( I V t h stage) are reduced. We assume that thrombocyte count diminution is due 
to the action of some factors. As already outlined, injected T R had a strong throm­
bocytopenic effect accompanied by a rapid plasma thrombocytopoietin ac t iv i ty 
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Fig. I . Changes of thrombocyte count un­
der the influence of IP , PR and PS in an 
acute thrombocytopenia after thrombo­
plastin injection. Data are presented as x 
and Sx. The difference in per cent is cal­
culated towards initial values accepted 
for 100 per cent 
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is stronger expressed than this of the control ones (with 30,96 per cent) we can 
suppose that P R possesses also an expressed thrombocytopenic effect. T h i s con­
clusion is confirmed by literature data (3, 15) and our own investigations (7) . 
I t is also probably that P R induces thrombosthenin increase. Bone marrow mega-
karyocyte increase is most probably a result of a fulfilled negative feed-back me¬
chanism brought into play by thrombocyte reduction (4, 14). The changes of dif¬
ferent stage megakaryocytes can be due to P R action. It suppresses carbohydrate 
metabolism, serotonin passage through thrombocyte membrane, 75Se-methionine 
incorporation into thrombocyte precursors, erythroid mitoses, etc. (2, 7, 10, 
12). I t is possible that just by means of direct suppression of stem cell and mega-
karyocyte metabolism the processes of differentiation in them can be delayed 
which is then followed by a strong young megakaryocyte accumulation and throm-
bocyte diminution. This P R effect confirms our previous studies on animals in 
normal conditions (7). The aforementioned changes can be the result of disturbed 
thrombocytopoietin realization on the background of beta-adrenoblockade. How­
ever, the question to what extent the functional state of both stem cell and mega-
• karyocyte beta-adrenergic receptors influences plasma thrombocytopoietin acti¬
vity realization and proliferation and differentiation of these cells requires fur­
ther investigations. 
We can conclude that I P beta-adrenoceptor stimulation has a positive effect 
on thrombocyte regeneration in an acute TR-induced thrombocytopenia while 
beta-adrenoblockade aggravates thrombocytopenia and worsens regeneration. 
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И З М Е Н Е Н И Я Т Р О М Б О Ц И Т О П О Э З А У К Р Ы С П Р И Н Е С Е Л Е К Т И В Н Ы Х 
Б Е Т А - А Д Р Э Н Е Р Г И Ч Е С К И Х В О З Д Е Й С Т В И Я Х В У С Л О В И Я Х 
О С Т Р О Й Т Р О М Б О Ц И Т О П Е Н И И 
Я . Негрев 
Р Е З Ю М Е 
В результате 24-ех часового эксперимента на крысах самцах устанавливается, что 
применение изопреналина (неселективного бета-адрэностимулятора) + тромбопластин вы­
зывает незначительное увеличение тромбоцитов, в то время как число мегакариоцитов воз­
растает на 50 % (р<0,001) , при увеличении числа мегакариоцитов I I I стадии на 16 % ( р < 
<0,001) и IV стадии — н а 263 % (р<0,001); наблюдается также уменьшение их числа в 
I стадии. Введение пропранолола (неселективного бгта-адреноблокера) + тромбопластин 
вызывает понижение числа тромбоцитов на 51,97 % (р<0 ,001) , что сопровождается уве­
личением числа мегакариоцитов на 44 % (р<0 ,001) . Это происходит за счет молодых 
форм мегакариоцитов — I и I I стадии и частично I I I стадии. У контрольной группы жи­
вотных, которым вводилась физиологическая сыворотка ;+ тромбопластин, устанавливает­
ся уменьшение числа тромбоцитов на 30,96 % (р<0,001) . 
Автором сделан вывод, что регуляция тромбоцитопоэза при острой тромбоцитопении 
зависит от функционального состояния бета-адрэнергических рецепторов. v , ; 
